This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

China unveils typical cases of cross-agency efforts to combat AI-generated rumors

( June 16, 2025, 04:23 GMT | Official Statement) -- MLex Summary: China's Internet regulator-affiliated center for reporting illegal and harmful information and the China Association for Science and Technology have unveiled typical cases that highlight cross-agency cooperation in debunking AI-generated rumors. The cases illustrate efforts to curb the spread of misleading narratives — ranging from false claims about earthquake disasters and fabricated data dressed up as professional reports to the deliberate distortion of official policies affecting public welfare. Authorities also noted attempts to discredit urban management and market supervision bodies. Regulators are urging online platforms to meet their content-review obligations and streamline reporting channels, while emphasizing that in-platform social media accounts must adhere to content-labeling requirements. The statement is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections